Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Oana Moldoveanu"'
Autor:
Catalin Baston, Andreea Ioana Parosanu, Mihaela Mihai, Oana Moldoveanu, Ioana Miruna Stanciu, Cornelia Nitipir
Publikováno v:
Diagnostics, Vol 14, Iss 5, p 553 (2024)
Tumor-to-tumor metastasis (TTM) is a rare phenomenon documented in patients with multiple primary cancers. This condition is defined as a metastasis between two true primary tumors. The most frequently reported recipient tumor is renal cell carcinoma
Externí odkaz:
https://doaj.org/article/d23d71780ef64a5daf0ea9cecec5fa48
Autor:
Andreea Ioana Parosanu, Cristina Florina Pirlog, Cristina Orlov Slavu, Ioana Miruna Stanciu, Horia-Teodor Cotan, Radu Constantin Vrabie, Ana-Maria Popa, Mihaela Olaru, Cristian Iaciu, Lucian Ioan Bratu, Ionut Florian Baicoianu, Oana Moldoveanu, Catalin Baston, Cornelia Nițipir
Publikováno v:
Current Oncology, Vol 30, Iss 2, Pp 2457-2464 (2023)
Background: Metastatic renal cell carcinoma (mRCC) is an aggressive cancer characterised by an increased recurrence rate and an inadequate response to treatment. This study aimed to investigate the importance of the neutrophil-to-lymphocyte ratio (NL
Externí odkaz:
https://doaj.org/article/0895789e72fe44cf8e12d3a27289df91
Autor:
Andreea Parosanu, Miruna Stanciu, Cristina Parlog, Cristina Orlov, Mihaela Olaru, Ana Maria Popa, Horia Cotan, Radu Vrabie, Cristian Iaciu, Oana Moldoveanu, Catalin Baston, Cornelia Nitipir
Publikováno v:
International Journal of Innovative Research in Medical Science. 7:743-745
Background: The incidence of metastatic renal cell carcinoma has steadily increased. Therefore, it is essential to identify precise biomarkers to predict survival and improve clinical care. Objectives: This study aimed to evaluate potential prognosti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3a02cf0405230701eaab48ca3256f451
https://doi.org/10.23958/ijirms/vol07-i12/1578
https://doi.org/10.23958/ijirms/vol07-i12/1578
Autor:
Andreea Parosanu, Ioana Miruna Stanciu, Cristina Pirlog, Cristina Orlov Slavu, Horia Cotan, Cristian Iaciu, Ana Maria Popa, Mihaela Olaru, Oana Moldoveanu, Baston Catalin, Cornelia Nitipir
Publikováno v:
Cureus. 14(10)
With recent advances in oncology, immune checkpoint inhibitors (ICIs) have become a milestone in immuno-oncology. Unfortunately, although ICIs have demonstrated improved clinical efficacy in a broad spectrum of cancers, many patients do not respond t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::931b95fdb74188b0eb3d1b681ae0aced
https://pubmed.ncbi.nlm.nih.gov/36451642
https://pubmed.ncbi.nlm.nih.gov/36451642